Geron Corporation (Nasdaq: GERN) Makes NASDAQ Top Gainers List on FDA News
March 15, 2024 (Globalinvestorideas.com Newswire) Biotech Stock News Bites – Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company developing investigational first-in-class telomerase inhibitor, imetelstat, to treat hematologic malignancies, has…